BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
Loading...
Loading...

Radioligand Assay Pages on BioPortfolio:

BioPortfolio - Indepth Browse
... Test | Radioimmunotherapy | Radioisotope Dilution Technique | Radioisotope Renography | Radioisotope Teletherapy | Radioligand Assay | Radiologic Health
...
http://www.bioportfolio.com/indepth/search/R.htm...

Biotechnology, Pharmaceutical and Life Science Email addresses for ...
Pharmaceutical, Drug Development and Discovery email list · Immunology email list · Neurodegeneration email list · ELISA - Enzyme Linked Immunosorbent Assay
...
http://www.bioportfolio.com/advertis/bioemail.htm...

Stakeholder Opinions: Diagnostics in Neurology - Predictive ...
In vitro assay companies 74 Benefit to pharmaceutical companies is substantial 75 ... Beta-amyloid radioligands using PET scans 95 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_410.html...

Table of Contents
Improved assay technology for the evaluation of airway therapeutic activity ..... as anti-cancer agents · Radioligand therapy: Targeting tumors with labeled
...
http://www.bioportfolio.com/tableof.htm...

Results from other life science and pharmaceutical sites:

Detection by Radioligand Assay of Antibodies against Borna Disease ...
Using a radioligand assay, which preserves the natural form of the antigen, antibodies against Borna disease virus nucleoprotein and phosphoprotein were ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=11...

Establishment of a novel radioligand assay using e...[J Hepatol ...
Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1
antibody ...
http://www.ncbi.nlm.nih.gov/pubmed/9210629...

A new approach to cytochrome CYP2D6 antibody detection in ...
In an attempt to set up a more sensitive detection assay we developed a quantitative immunoprecipitation radioligand assay using a 35S-methionine-
labelled ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=19...

Statistical analysis of radioligand assay data. [Methods Enzymol ...
PubMed is a service of the US National Library of Medicine that includes over 16 million citations from MEDLINE and other life science journals for ...
http://www.ncbi.nlm.nih.gov/pubmed/1128249...

Detection of liver kidney microsomal type 1 antibody using ...
The in house radioligand assay used in our study was based on a previously .... Establishment of a novel radioligand assay using eukaryotically expressed ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=17...

[Improved radioligand assay of insulin autoantibod...[Zhong Nan Da ...
OBJECTIVE: To establish an improved radioligand assay of insulin autoantibody ( IAA) and to investigate the diagnostic role of IAA in type 1 diabetes (T1DM).
...
http://www.ncbi.nlm.nih.gov/pubmed/16134593...

Comparisons of standard curve-fitting methods to quantitate ...
[PubMed]; DeLean A, Munson PJ, Rodbard D. Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=27...

Kidney International - Characterization of receptors for ...
Radioligand receptor assay was carried out to examine the specificity with ... for 20 hours at 4°C. Radioligand assay was performed as described in the ...
http://www.nature.com/ki/journal/v58/n5/full/4491853a.html...

pjp3'2003.vp:CorelVentura 7.0
Radioligand binding assay. Radioligand binding assays were conducted as. previously described [27]. The tissue was thawed ...
http://www.if-pan.krakow.pl/pjp/pdf/2003/3_455.pdf...

International Journal of Obesity - Type II diabetes mellitus and ...
Antiinsulin antibodies were determined by a radioligand assay supplied by Medipan Diagnostica (Hamburg, Germany). The presence of anti-GAD65 antibodies
was ...
http://www.nature.com/ijo/journal/v28/n2/full/0802555a.html...

Google Custom Search

Search
  

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo